Advertisement

More articles from Cancer Immunology Miniature

  • Colon Cancer 9p24.1 Copy-number Gain and PD-1 Blockade
    Anne Hansen Ree, Vigdis Nygaard, Hege G. Russnes, Daniel Heinrich, Vegard Nygaard, Christin Johansen, Inger Riise Bergheim, Eivind Hovig, Klaus Beiske, Anne Negård, Anne-Lise Børresen-Dale, Kjersti Flatmark, Gunhild M. Mælandsmo
    Cancer Immunology Research May 2019, 7 (5) 701-706; DOI: 10.1158/2326-6066.CIR-18-0777
  • HLA-A2 Restricted Mutated p53-Reactive TCRs
    Winifred Lo, Maria Parkhurst, Paul F. Robbins, Eric Tran, Yong-Chen Lu, Li Jia, Jared J. Gartner, Anna Pasetto, Drew Deniger, Parisa Malekzadeh, Thomas E. Shelton, Todd Prickett, Satyajit Ray, Scott Kivitz, Biman C. Paria, Isaac Kriley, David S. Schrump, Steven A. Rosenberg
    Cancer Immunology Research Apr 2019, 7 (4) 534-543; DOI: 10.1158/2326-6066.CIR-18-0686
  • Autoantibodies under Immune-Checkpoint Inhibitors
    Emma C. de Moel, Elisa A. Rozeman, Ellen H. Kapiteijn, Els M.E. Verdegaal, Annette Grummels, Jaap A. Bakker, Tom W.J. Huizinga, John B. Haanen, René E.M. Toes, Diane van der Woude
    Cancer Immunology Research Jan 2019, 7 (1) 6-11; DOI: 10.1158/2326-6066.CIR-18-0245
  • Pancreatic Atrophy as a Cause of Anti–PD-1–Induced Diarrhea
    Yael Eshet, Erez Nissim Baruch, Ronnie Shapira-Frommer, Yael Steinberg-Silman, Teodor Kuznetsov, Guy Ben-Betzalel, Sameh Daher, Iris Gluck, Nethanel Asher, Sara Apter, Jacob Schachter, Jair Bar, Ben Boursi, Gal Markel
    Cancer Immunology Research Dec 2018, 6 (12) 1453-1458; DOI: 10.1158/2326-6066.CIR-17-0659
  • PD-1 Blockade Therapy for Kaposi Sarcoma
    Natalie Galanina, Aaron M. Goodman, Philip R. Cohen, Garrett M. Frampton, Razelle Kurzrock
    Cancer Immunology Research Oct 2018, 6 (10) 1129-1135; DOI: 10.1158/2326-6066.CIR-18-0121
  • Checkpoint Inhibitors in Alveolar Soft-Part Sarcoma
    Jeremy Lewin, Scott Davidson, Nathaniel D. Anderson, Beatrice Y. Lau, Jacalyn Kelly, Uri Tabori, Samer Salah, Marcus O. Butler, Kyaw L. Aung, Adam Shlien, Brendan C. Dickson, Albiruni R. Abdul Razak
    Cancer Immunology Research Sep 2018, 6 (9) 1001-1007; DOI: 10.1158/2326-6066.CIR-18-0037
  • Post-alloHSCT Antibodies Target Siglec-6 on CLL Cells
    Jing Chang, Haiyong Peng, Brian C. Shaffer, Sivasubramanian Baskar, Ina C. Wecken, Matthew G. Cyr, Gustavo J. Martinez, Jo Soden, Jim Freeth, Adrian Wiestner, Christoph Rader
    Cancer Immunology Research Sep 2018, 6 (9) 1008-1013; DOI: 10.1158/2326-6066.CIR-18-0102
  • PD-1/PD-L1 Inhibition in Non–Clear Cell Renal Cell Carcinoma
    Rana R. McKay, Dominick Bossé, Wanling Xie, Stephanie A.M. Wankowicz, Abdallah Flaifel, Raphael Brandao, Aly-Khan A. Lalani, Dylan J. Martini, Xiao X. Wei, David A. Braun, Eliezer Van Allen, Daniel Castellano, Guillermo De Velasco, J. Connor Wells, Daniel Y. Heng, Andre P. Fay, Fabio A. Schutz, JoAnn Hsu, Sumanta K. Pal, Jae Lyun Lee, James J. Hsieh, Lauren C. Harshman, Sabina Signoretti, Robert J. Motzer, Darren Feldman, Toni K. Choueiri
    Cancer Immunology Research Jul 2018, 6 (7) 758-765; DOI: 10.1158/2326-6066.CIR-17-0475
  • Immune-Related Sarcoid-Like Granulomatosis of the Lung
    Mizuki Nishino, Lynette M. Sholl, Mark M. Awad, Hiroto Hatabu, Philippe Armand, F. Stephen Hodi
    Cancer Immunology Research Jun 2018, 6 (6) 630-635; DOI: 10.1158/2326-6066.CIR-17-0715
  • DC Vaccine Engineered with PD-L siRNA and IL15/IL15Rα mRNA
    Johan M.J. Van den Bergh, Evelien L.J.M. Smits, Zwi N. Berneman, Tim J.A. Hutten, Hans De Reu, Viggo F.I. Van Tendeloo, Harry Dolstra, Eva Lion, Willemijn Hobo
    Cancer Immunology Research Aug 2017, 5 (8) 710-715; DOI: 10.1158/2326-6066.CIR-16-0336

Pages